Lavita Technologies Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Out of Business

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Out of Business

Lavita Technologies General Information

Description

Operator of a neuromodulation company intended to develop healthcare products for the treatment of autoimmune inflammatory diseases. The company's product utilizes a catheter-based percutaneous approach to deliver targeted and localized energy to modulate and reset nerve activity specific to the inflammation in rheumatoid arthritis, inflammatory bowel disease, and metabolic disorders, enabling patients to get quality treatment.

Contact Information

Website
www.lavitta.co.uk
Formerly Known As
Mbco1048 Ltd
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • C K R House
  • 70 East Hill
  • Dartford DA1 1RZ
  • England, United Kingdom
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Services
Vertical(s)
HealthTech
Corporate Office
  • C K R House
  • 70 East Hill
  • Dartford DA1 1RZ
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lavita Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 18-Mar-2014 Completed Out of Business
1. Accelerator/Incubator Completed Generating Revenue
To view Lavita Technologies’s complete valuation and funding history, request access »

Lavita Technologies Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Lavita Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2016532497-A Method and apparatus for treating autoimmune diseases by ablation neuromodulation Pending 14-Aug-2013
EP-3033021-A2 Methods and apparatuses for treating auto-immune diseases by ablative neuromodulation Inactive 14-Aug-2013
US-20160199127-A1 Methods and apparatuses for treating auto-immune diseases by ablative neuromodulation Inactive 14-Aug-2013
WO-2015022668-A2 Methods and apparatuses for treating auto-immune diseases by ablative neuromodulation Inactive 14-Aug-2013
WO-2015022668-A3 Methods and apparatuses for treating auto-immune diseases by ablative neuromodulation Inactive 14-Aug-2013 A61B18/1492
To view Lavita Technologies’s complete patent history, request access »

Lavita Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Lavita Technologies FAQs

  • When was Lavita Technologies founded?

    Lavita Technologies was founded in 2011.

  • Where is Lavita Technologies headquartered?

    Lavita Technologies is headquartered in Dartford, United Kingdom.

  • What is the size of Lavita Technologies?

    Lavita Technologies has 5 total employees.

  • What industry is Lavita Technologies in?

    Lavita Technologies’s primary industry is Therapeutic Devices.

  • Is Lavita Technologies a private or public company?

    Lavita Technologies is a Private company.

  • What is Lavita Technologies’s current revenue?

    The current revenue for Lavita Technologies is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process